Glenmark launches Sitagliptin and its FDC at affordable price
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
The AICVD tool can predict the risk of cardiovascular disease.
Mittal has previously managed Multiple backed Vikram Hospital as CEO and was associated with Fortis Escorts Heart Institute as zonal director.
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
Subscribe To Our Newsletter & Stay Updated